CUFinder

Kris Wood

Kris Wood

Duke University

H-index: 27

North America-United States

Contact Kris Wood

About Kris Wood

Kris Wood, With an exceptional h-index of 27 and a recent h-index of 24 (since 2020), a distinguished researcher at Duke University, specializes in the field of cancer, genomics, targeted therapies, cell signaling.

His recent articles reflect a diverse array of research interests and contributions to the field:

A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors

Drug dependence in cancer is exploitable by optimally constructed treatment holidays

Endogenous and imposed determinants of apoptotic vulnerabilities in cancer

MCB-613 exploits a collateral sensitivity in drug resistant EGFR-mutant non-small cell lung cancer through covalent inhibition of KEAP1

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer

CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer

Hyperactivation of oncogenic driver pathways as a precision therapeutic strategy

Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13

Kris Wood Information

University

Position

___

Citations(all)

4018

Citations(since 2020)

2236

Cited By

2646

hIndex(all)

27

hIndex(since 2020)

24

i10Index(all)

42

i10Index(since 2020)

39

Email

University Profile Page

Google Scholar

Kris Wood Skills & Research Interests

cancer

genomics

targeted therapies

cell signaling

Top articles of Kris Wood

A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors

Molecular Cancer Therapeutics

2024/4/8

Drug dependence in cancer is exploitable by optimally constructed treatment holidays

Nature Ecology & Evolution

2024/1

Endogenous and imposed determinants of apoptotic vulnerabilities in cancer

2023/2/1

MCB-613 exploits a collateral sensitivity in drug resistant EGFR-mutant non-small cell lung cancer through covalent inhibition of KEAP1

bioRxiv

2023/1/19

Li Qin
Li Qin

H-Index: 6

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer

Cancer research

2023/1/4

Sehrish Javaid
Sehrish Javaid

H-Index: 1

Elisa Baldelli
Elisa Baldelli

H-Index: 13

Mariaelena Pierobon
Mariaelena Pierobon

H-Index: 22

CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer

Molecular Cancer Research

2023/11/1

Hyperactivation of oncogenic driver pathways as a precision therapeutic strategy

Nature Genetics

2023/10

Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13

Proceedings of the National Academy of Sciences

2023/9/19

Annie Liu
Annie Liu

H-Index: 19

Qiang Chen
Qiang Chen

H-Index: 15

Alejandro Barrera
Alejandro Barrera

H-Index: 10

Jiaxing Lin
Jiaxing Lin

H-Index: 5

Zhecheng Sheng
Zhecheng Sheng

H-Index: 1

Timothy E Reddy
Timothy E Reddy

H-Index: 35

Sublethal engagement of apoptotic pathways in residual cancer

2023/8/10

ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1

Proceedings of the National Academy of Sciences

2023/4/18

Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

Nature Communications

2023/3/14

Challenges and emerging opportunities for targeting mTOR in cancer

Cancer research

2022/11/2

Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies

NPJ Precision Oncology

2022/10/23

Min Lu
Min Lu

H-Index: 3

Annie Liu
Annie Liu

H-Index: 19

Zhecheng Sheng
Zhecheng Sheng

H-Index: 1

Cancer genes disfavoring T cell immunity identified via integrated systems approach

Cell reports

2022/8/2

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Nature cancer

2022/7

Jacob Hoj
Jacob Hoj

H-Index: 5

Min Lu
Min Lu

H-Index: 3

Jiaxing Lin
Jiaxing Lin

H-Index: 5

Mariaelena Pierobon
Mariaelena Pierobon

H-Index: 22

Zhecheng Sheng
Zhecheng Sheng

H-Index: 1

Ashutosh Chilkoti
Ashutosh Chilkoti

H-Index: 67

Emanuel Petricoin
Emanuel Petricoin

H-Index: 51

A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models

The Journal of Clinical Investigation

2022/6/15

Zheng Zhong
Zheng Zhong

H-Index: 4

Drivers of intrinsic resistance

Nature chemical biology

2022/6

Concurrent inhibition of ERK and farnesyltransferase suppresses the growth of HRAS mutant head and neck squamous cell carcinoma

Molecular cancer therapeutics

2022/5/4

Sehrish Javaid
Sehrish Javaid

H-Index: 1

Antje Schaefer
Antje Schaefer

H-Index: 10

Mariaelena Pierobon
Mariaelena Pierobon

H-Index: 22

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Science translational medicine

2022/3/30

Min Lu
Min Lu

H-Index: 3

A high throughput proliferation and cytotoxicity assay for co-cultured isogenic cell lines

MethodsX

2022/1/1

See List of Professors in Kris Wood University(Duke University)